M. Mayaux, M. Burgard, and J. Teglas, Neonatal characteristics in rapidly progressive perinatally acquired HIV-1 disease. The French Pediatric HIV Infection Study Group, JAMA: The Journal of the American Medical Association, vol.275, issue.8, pp.606-610, 1996.
DOI : 10.1001/jama.275.8.606

J. Ioannidis, A. Tatsioni, and E. Abrams, Maternal viral load and rate of disease progression among vertically HIV-1-infected children, AIDS, vol.18, issue.1, pp.99-108, 2004.
DOI : 10.1097/00002030-200401020-00012

E. Obimbo, D. Wamalwa, and B. Richardson, Pediatric HIV-1 in Kenya: Pattern and Correlates of Viral Load and Association With Mortality, JAIDS Journal of Acquired Immune Deficiency Syndromes, vol.51, issue.2, pp.209-215, 2009.
DOI : 10.1097/QAI.0b013e31819c16d8

A. Kourtis, C. Ibegbu, and A. Nahmias, Early Progression of Disease in HIV-Infected Infants with Thymus Dysfunction, New England Journal of Medicine, vol.335, issue.19, pp.1431-1436, 1996.
DOI : 10.1056/NEJM199611073351904

F. Buseyne, M. Burgard, and J. Teglas, Early HIV-Specific Cytotoxic T Lymphocytes and Disease Progression in Children Born to HIV-Infected Mothers, AIDS Research and Human Retroviruses, vol.14, issue.16, pp.1435-1444, 1998.
DOI : 10.1089/aid.1998.14.1435

R. Biggar, M. Janes, and R. Pilon, Virus Levels in Untreated African Infants Infected with Human Immunodeficiency Virus Type 1, The Journal of Infectious Diseases, vol.180, issue.6, pp.1838-1843, 1999.
DOI : 10.1086/315122

K. Mcintosh, A. Shevitz, and D. Zaknun, Age- and Time-related Changes in Extracellular Viral Load in Children Vertically Infected by Human Immunodeficiency Virus, The Pediatric Infectious Disease Journal, vol.15, issue.12, pp.1087-1091, 1996.
DOI : 10.1097/00006454-199612000-00006

M. Bunders, C. Loos, . Van-der, and P. Klarenbeek, Memory CD4+CCR5+ T cells are abundantly present in the gut of newborn infants to facilitate mother-to-child transmission of HIV-1, Blood, vol.120, issue.22, pp.4383-4390, 2012.
DOI : 10.1182/blood-2012-06-437566

S. Schönland, J. Zimmer, and C. Lopez-benitez, Homeostatic control of T-cell generation in neonates, Blood, vol.102, issue.4, pp.1428-1434, 2003.
DOI : 10.1182/blood-2002-11-3591

F. Buseyne, D. Scott-algara, and N. Bellal, The Frequency of HIV???Specific Interferon????????Producing CD8 T Cells Is Associated with Both Age and Level of Antigenic Stimulation in HIV???1???Infected Children, The Journal of Infectious Diseases, vol.192, issue.10, pp.1781-1786, 2005.
DOI : 10.1086/497152
URL : https://hal.archives-ouvertes.fr/pasteur-00013707

N. Tobin and G. Aldrovandi, Immunology of pediatric HIV infection, Immunological Reviews, vol.51, issue.Suppl, pp.143-169, 2013.
DOI : 10.1111/imr.12074

D. Hartigan-o-'connor, K. Abel, and J. Mccune, T cells by infant but not adult macaque regulatory T cells: implications for SIV disease progression, The Journal of Experimental Medicine, vol.7, issue.2, pp.2679-2692, 2007.
DOI : 10.1097/00002030-199801000-00001

M. Muenchhoff, A. Prendergast, and P. Goulder, Immunity to HIV in Early Life, Frontiers in Immunology, vol.369, issue.7, p.391, 2014.
DOI : 10.1002/14651858.CD003510.pub3

A. Faye, J. Chenadec, . Le, and C. Dollfus, Early versus Deferred Antiretroviral Multidrug Therapy in Infants Infected with HIV Type 1, Clinical Infectious Diseases, vol.39, issue.11, pp.1692-1698, 2004.
DOI : 10.1086/425739

A. Violari, M. Cotton, and D. Gibb, Early Antiretroviral Therapy and Mortality among HIV-Infected Infants, New England Journal of Medicine, vol.359, issue.21, pp.2233-2244, 2008.
DOI : 10.1056/NEJMoa0800971
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2950021

C. Group, C. Sabin, and C. Smith, Response to combination antiretroviral therapy: variation by age, AIDS, vol.22, pp.1463-1473, 2008.

J. Lewis, A. Walker, and N. Klein, CD31+ Cell Percentage Correlation With Speed of CD4+ T-Cell Count Recovery in HIV-Infected Adults Is Reversed in Children: Higher Thymic Output May Be Responsible, Clinical Infectious Diseases, vol.55, issue.2, pp.304-307, 2012.
DOI : 10.1093/cid/cis374

A. Rossum, . Van, H. Scherpbier, E. Lochem, and . Van, Therapeutic immune reconstitution in HIV-1-infected children is independent of their age and pretreatment immune status, AIDS, vol.15, issue.17, pp.2267-2275, 2001.
DOI : 10.1097/00002030-200111230-00008

T. Goetghebuer, J. Chenadec, . Le, and E. Haelterman, Short- and Long-term Immunological and Virological Outcome in HIV-Infected Infants According to the Age at Antiretroviral Treatment Initiation, Clinical Infectious Diseases, vol.54, issue.6, pp.878-881, 2012.
DOI : 10.1093/cid/cir950

G. Fang, G. Zhu, and H. Burger, Minimizing DNA recombination during long RT-PCR, Journal of Virological Methods, vol.76, issue.1-2, pp.139-148, 1998.
DOI : 10.1016/S0166-0934(98)00133-5

I. Bains, R. Thiébaut, and A. Yates, Quantifying Thymic Export: Combining Models of Naive T Cell Proliferation and TCR Excision Circle Dynamics Gives an Explicit Measure of Thymic Output, The Journal of Immunology, vol.183, issue.7, pp.4329-4336, 2009.
DOI : 10.4049/jimmunol.0900743

I. Bains, R. Antia, and R. Callard, Quantifying the development of the peripheral naive CD4+ T-cell pool in humans, Blood, vol.113, issue.22, pp.5480-5487, 2009.
DOI : 10.1182/blood-2008-10-184184

E. Wils, B. Holt, . Van-der, and A. Broers, Insufficient recovery of thymopoiesis predicts for opportunistic infections in allogeneic hematopoietic stem cell transplant recipients, Haematologica, vol.96, issue.12, pp.1846-1854, 2011.
DOI : 10.3324/haematol.2011.047696

J. Mold, J. Michaëlsson, and T. Burt, Maternal Alloantigens Promote the Development of Tolerogenic Fetal Regulatory T Cells in Utero, Science, vol.322, issue.5907, pp.1562-1565, 2008.
DOI : 10.1126/science.1164511

O. Levy, Innate immunity of the newborn: basic mechanisms and clinical correlates, Nature Reviews Immunology, vol.21, issue.5, pp.379-390, 2007.
DOI : 10.1038/nri2075

P. Corbeau and J. Reynes, Immune reconstitution under antiretroviral therapy: the new challenge in HIV-1 infection, Blood, vol.117, issue.21, pp.5582-5590, 2011.
DOI : 10.1182/blood-2010-12-322453

K. Luzuriaga, M. Mcmanus, and M. Catalina, Early Therapy of Vertical Human Immunodeficiency Virus Type 1 (HIV-1) Infection: Control of Viral Replication and Absence of Persistent HIV-1-Specific Immune Responses, Journal of Virology, vol.74, issue.15, pp.6984-6991, 2000.
DOI : 10.1128/JVI.74.15.6984-6991.2000

M. Cotton, A. Violari, and K. Otwombe, Early time-limited antiretroviral therapy versus deferred therapy in South African infants infected with HIV: results from the children with HIV early antiretroviral (CHER) randomised trial, The Lancet, vol.382, issue.9904, pp.1555-1563, 2013.
DOI : 10.1016/S0140-6736(13)61409-9

H. Payne, N. Mkhize, and K. Otwombe, Reactivity of routine HIV antibody tests in children who initiated antiretroviral therapy in early infancy as part of the Children with HIV Early Antiretroviral Therapy (CHER) trial: a retrospective analysis, The Lancet Infectious Diseases, vol.15, issue.7, pp.803-809, 2015.
DOI : 10.1016/S1473-3099(15)00087-0

C. Goujard, M. Bonarek, and L. Meyer, CD4 Cell Count and HIV DNA Level Are Independent Predictors of Disease Progression after Primary HIV Type 1 Infection in Untreated Patients, Clinical Infectious Diseases, vol.42, issue.5, pp.709-715, 2006.
DOI : 10.1086/500213

L. Hocqueloux, V. Avettand-fènoël, and S. Jacquot, Long-term antiretroviral therapy initiated during primary HIV-1 infection is key to achieving both low HIV reservoirs and normal T cell counts, Journal of Antimicrobial Chemotherapy, vol.68, issue.5, pp.1169-1178, 2013.
DOI : 10.1093/jac/dks533

N. Chomont, M. Far, and P. El-,-ancuta, HIV reservoir size and persistence are driven by T cell survival and homeostatic proliferation, Nature Medicine, vol.45, issue.8, pp.893-900, 2009.
DOI : 10.1038/nm.1972

A. Chéret, C. Bacchus-souffan, and V. Avettand-fenoël, Combined ART started during acute HIV infection protects central memory CD4+ T cells and can induce remission, J Antimicrob Chemother, vol.70, pp.2108-2120, 2015.

J. Ananworanich, T. Puthanakit, and P. Suntarattiwong, Reduced markers of HIV persistence and restricted HIV-specific immune responses after early antiretroviral therapy in children, AIDS, vol.28, issue.7, pp.1015-1020, 2014.
DOI : 10.1097/QAD.0000000000000178

A. Bitnun, L. Samson, and T. Chun, Early Initiation of Combination Antiretroviral Therapy in HIV-1-Infected Newborns Can Achieve Sustained Virologic Suppression With Low Frequency of CD4+ T Cells Carrying HIV in Peripheral Blood, Clinical Infectious Diseases, vol.59, issue.7, pp.1012-1019, 2014.
DOI : 10.1093/cid/ciu432

K. Luzuriaga, B. Tabak, and M. Garber, HIV Type 1 (HIV-1) Proviral Reservoirs Decay Continuously Under Sustained Virologic Control in HIV-1???Infected Children Who Received Early Treatment, Journal of Infectious Diseases, vol.210, issue.10, pp.1529-1538, 2014.
DOI : 10.1093/infdis/jiu297

D. Persaud, P. Palumbo, and C. Ziemniak, Dynamics of the resting CD4+ T-cell latent HIV reservoir in infants initiating HAART less than 6 months of age, AIDS, vol.26, issue.12, pp.1483-1490, 2012.
DOI : 10.1097/QAD.0b013e3283553638

L. Hocqueloux, T. Prazuck, and V. Avettand-fenoel, Long-term immunovirologic control following antiretroviral therapy interruption in patients treated at the time of primary HIV-1 infection, AIDS, vol.24, issue.10, pp.1598-1601, 2010.
DOI : 10.1097/QAD.0b013e32833b61ba

A. Sáez-cirión, C. Bacchus, and L. Hocqueloux, Post-Treatment HIV-1 Controllers with a Long-Term Virological Remission after the Interruption of Early Initiated Antiretroviral Therapy ANRS VISCONTI Study, PLoS Pathogens, vol.22, issue.16, p.1003211, 2013.
DOI : 10.1371/journal.ppat.1003211.s007

D. Scott-algara, C. Didier, and V. Arnold, Post-treatment controllers have particular NK celles with high anti-HIV capacity: VISCONTI study, 22 nd Conference on Retroviruses and Opportunistic Infections, 2015.

D. Persaud, H. Gay, and C. Ziemniak, Absence of Detectable HIV-1 Viremia after Treatment Cessation in an Infant, New England Journal of Medicine, vol.369, issue.19, pp.1828-1835, 2013.
DOI : 10.1056/NEJMoa1302976

K. Luzuriaga, H. Gay, and C. Ziemniak, Viremic Relapse after HIV-1 Remission in a Perinatally Infected Child, New England Journal of Medicine, vol.372, issue.8, pp.786-788, 2015.
DOI : 10.1056/NEJMc1413931

V. Giacomet, D. Trabattoni, and N. Zanchetta, No cure of HIV infection in a child despite early treatment and apparent viral clearance, The Lancet, vol.384, issue.9950, p.1320, 2014.
DOI : 10.1016/S0140-6736(14)61405-7

M. Martínez-bonet, M. Puertas, and C. Fortuny, Establishment and Replenishment of the Viral Reservoir in Perinatally HIV-1-infected Children Initiating Very Early Antiretroviral Therapy, Clinical Infectious Diseases, vol.61, issue.7, pp.1169-1178, 2015.
DOI : 10.1093/cid/civ456

K. Butler, P. Gavin, and S. Coughlan, Rapid Viral Rebound After 4 Years of Suppressive Therapy in a Seronegative HIV-1 Infected Infant Treated From Birth, The Pediatric Infectious Disease Journal, vol.34, issue.3, pp.48-51, 2015.
DOI : 10.1097/INF.0000000000000570

P. Frange, A. Faye, and V. Avettand-fenoel, HIV-1 virological remission lasting more than 12 years after interruption of early initiated antiretroviral therapy in a perinatally infected teenager enrolled in the French Pediatric Cohort ANRS EPF-CO10, Lancet HIV, p.2015

C. Stuart, J. Hazebergh, M. Hamann, and D. , The Dominant Source of CD4+ and CD8+ T-Cell Activation in HIV Infection Is Antigenic Stimulation, JAIDS Journal of Acquired Immune Deficiency Syndromes, vol.25, issue.3, pp.203-211, 2000.
DOI : 10.1097/00126334-200011010-00001

M. Rizk, L. Du, and C. Bennetto-hood, Population pharmacokinetic analysis of raltegravir pediatric formulations in HIV-infected children 4 weeks to 18 years of age, The Journal of Clinical Pharmacology, vol.867, issue.6), pp.748-756, 2015.
DOI : 10.1002/jcph.493